MK-6837 is under clinical development by Merck and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...

VI-0810 is under development for the treatment of diabetes. Vivus, a subsidiary of Icahn Enterprises LP, is developing drugs for the treatment of exocrine pancreatic insufficiency, obesity and ...

The creation of materials that are highly thermal-energy dense can now be achieved by combining two components that work together to simultaneously undergo a solid-to-liquid phase transition and a ...

With a bold 25.5% reduction in carbon emissions and a 50% transition to green power, global textile and apparel leader ...

"As Sapient’s Founder, I am dedicated to the company’s mission and am excited about our next phase impacting human ... in charting Sapient’s continued success," said Dr.

Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.

it will be good and beneficial for the country but a smooth phase of transition must be ensured. Such a change must not be attempted overnight,” cautioned Mr. Kishor while speaking to media ...

Deconfined quantum criticality represents a novel class of phase transitions that fall outside ... material candidates show a weakly-first order transition. Here the authors introduce a Nordic ...

Detailed price information for Bhp Billiton Ltd ADR (BHP-N) from The Globe and Mail including charting and trades.

Scientists have studied the success rate of Trodelvy and found it to be effective in managing certain aspects of these cancers in some people. Trodelvy can help improve survival rates for people ...

President-elect Donald Trump‘s transition team is planning to eliminate a $7,500 electric vehicle tax credit that helps ...

Once again, we're back with our annual power ranking of US launch companies. 2024 was the third year Ars compiled a list of ...